Roche to accumulate US agency Poseida Therapeutics in $1.5 billion deal
ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in a money deal price as much as $1.5 ...
ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in a money deal price as much as $1.5 ...